the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients
NCT07692256
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Heart Failure
Interventions
DRUG:
Empagliflozin (EMPA)
DRUG:
Standard medical treatment
Sponsor
Ain Shams University